Tag Archives: 3D Printed Drugs Market Share

The Market for 3D Printed Drugs Offers new hope in the dysphagia fight

According to the report published by Allied Market Research, The Global 3D Printed Drugs Market Size was valued at USD 278 million in 2020, and it is estimated to surpass around USD 522 million by 2030, with a registered CAGR of 6.5% from 2020 to 2030. 3D printed drugs are drugs created by 3D printing …

Continue reading “The Market for 3D Printed Drugs Offers new hope in the dysphagia fight”

3D Printed Drugs Market Trends, Business Strategies and Opportunities With Key Players Analysis

3D printed drugs are drugs created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have a porous structure that can rapidly disintegrate in the mouth. Aprecia Pharmaceuticals Companys SPRITAM levetiracetam is the first 3D printed drug, launched in the US in August 2015. Approved by the Food …

Continue reading “3D Printed Drugs Market Trends, Business Strategies and Opportunities With Key Players Analysis”